PrEP Archives -

Data sets up 2021 filings for Gilead’s twice-a-year HIV drug lenacapavir

https://pharmaphorum.com/news/data-sets-up-2021-filings-for-gileads-twice-a-year-hiv-drug-lenacapavir/

Gilead’s Descovy approved in HIV prophylaxis

https://pharmaphorum.com/news/gileads-descovy-approved-in-hiv-prophylaxis/

Gilead will challenge US government patent on PrEP drug Truvada

https://pharmaphorum.com/news/gilead-will-challenge-us-government-patent-on-prep-drug-truvada/

Gilead’s Descovy gets FDA panel OK for PrEP, but not for women

https://pharmaphorum.com/news/gileads-descovy-gets-fda-panel-ok-for-prep-but-not-for-women/

FDA reviewer backs Gilead’s Descovy for PrEP, but not in women

https://pharmaphorum.com/news/fda-reviewer-backs-gileads-descovy-for-prep-but-not-in-women/

MPs call for NHS funding for HIV prevention drug

https://pharmaphorum.com/news/mps-call-for-nhs-funding-for-hiv-truvada/

Landmark HIV prophylaxis trial to begin next month

https://pharmaphorum.com/news/hiv-prophylaxis-trial/

Scotland says yes to Truvada as PrEP

https://pharmaphorum.com/news/scotland-says-yes-truvada-prep/

NHS England confirms HIV prevention funding – but only via clinical trial

https://pharmaphorum.com/news/nhs-england-extend-hiv-prevention-programme/

Search